On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...